Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Minocycline for Drug-Resistant Epilepsy in NORSE
NCT05958069Unknown
- Sponsor
- Xijing Hospital
- Start
- Mar 2023
- Primary completion
- Mar 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of minocycline in epilepsy, sponsored by Xijing Hospital. Primary endpoints: Changes in seizure frequency at 24 months and Incidence of adverse events at 24 months. Status: unknown.
02
Drugs
minocycline
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT05958069.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05958069.